$64.22
-0.0600 (-0.0933%)
At Close: Jun 03, 2026
3 Medical Product Stocks Poised to Beat This Earnings Season
09:02am, Monday, 25'th Apr 2022
Medical product companies' results are likely to reflect base business recovery on a year-over-year basis. Let's see how ALC, ZBH and CSII are poised ahead of their earnings releases.
LabCorp (LH) to Report Q1 Earnings: What's in the Cards?
03:22pm, Friday, 22'nd Apr 2022 Zacks Investment Research
Robust base business growth and notable launches are likely to have contributed to LabCorp's (LH) Q1 performance.
Align Technology (ALGN) to Post Q1 Earnings: What's in Store?
01:05pm, Thursday, 21'st Apr 2022 Zacks Investment Research
Robust demand for iTero scanners and increasing Invisalign case submissions are expected to have contributed to Align Technology's (ALGN) Q1 performance.
Zacks Industry Outlook Highlights Alcon, STERIS and Abiomed
10:21am, Wednesday, 20'th Apr 2022 Zacks Investment Research
Alcon, STERIS and Abiomed have been highlighted in this Industry Outlook article.
3 Medical Instruments Stocks to Buy Despite Industry Headwinds
12:51pm, Tuesday, 19'th Apr 2022 Zacks Investment Research
The Zacks Medical - Instruments industry is growing on R&D investments. ALC, STE and ABMD are set to gain the most. Yet, demand for non-COVID businesses is on the decline with the new COVID variant di
3 Medical Instruments Stocks to Buy Despite Industry Headwinds
10:32am, Tuesday, 19'th Apr 2022
The Zacks Medical - Instruments industry is growing on R&D investments. ALC, STE and ABMD are set to gain the most.
4 'Double Discounted' CEFs Yielding Up To 9.1%
09:08am, Thursday, 14'th Apr 2022 Investing.comAlcon (ALC) Stock Rallies 4.7% Since Posting Q4 Earnings Beat
02:36pm, Tuesday, 12'th Apr 2022 Zacks Investment Research
Alcon (ALC) stock rallies on robust growth across all Surgical and Vision Care sales categories.
Alcon (ALC) Stock Rallies 4.7% Since Posting Q4 Earnings Beat
12:02pm, Tuesday, 12'th Apr 2022
Alcon (ALC) stock rallies on robust growth across all Surgical and Vision Care sales categories.
Alcon's (ALC) Surgical Arm Rebounds, New Launches Aid Growth
02:37pm, Monday, 11'th Apr 2022 Zacks Investment Research
In Vision Care, Alcon (ALC) continues to see strong demand for PRECISION1 and PRECISION1 for Astigmatism, which are the company's newest contact lenses for the mainstream market.
Alcon's (ALC) Surgical Arm Rebounds, New Launches Aid Growth
12:03pm, Monday, 11'th Apr 2022
In Vision Care, Alcon (ALC) continues to see strong demand for PRECISION1 and PRECISION1 for Astigmatism, which are the company's newest contact lenses for the mainstream market.
Needham Initiates Alcon Citing 'Visible Path to Sustainable Double-Digit EPS Growth'
04:19pm, Friday, 08'th Apr 2022 Benzinga
Needham is initiating coverage on Alcon AG (NYSE: ALC) with a Buy rating and a $95 price target.
The analysts believe Alcon has visibility into sustainable mid-single-digit or better revenue growt
Benzinga's Top Ratings Upgrades, Downgrades For April 8, 2022
02:03pm, Friday, 08'th Apr 2022 Benzinga
Upgrades
UBS upgraded the previous rating for First Republic Bank (NYSE:FRC) from Neutral to Buy. For the fourth quarter, First Republic Bank had an EPS of $2.02, compared to year-ago quarter EPS of $
Alcon (ALC) Publishes Dividend, New Board Member Addition Plans
04:21pm, Monday, 28'th Mar 2022 Zacks Investment Research
Alcon's 2022 AGM is set to take place in a closed format without the personal presence of shareholders.
Alcon (ALC) Publishes Dividend, New Board Member Addition Plans
01:33pm, Monday, 28'th Mar 2022
Alcon's 2022 AGM is set to take place in a closed format without the personal presence of shareholders.
Sign In
Buy ALC